Kate Farms, which specializes in plant-based, ready-to-use oral and tube feeding formulas, has rolled out its Core Essentials Peptide…
Charles Moore
Charles Moore is a syndicated columnist for several major Canadian print newspapers and the Science and Research Section editor for CF News Today.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Charles Moore
Scientists at Pennsylvania State University have developed a relatively inexpensive, easy-to-use system for diagnosing cystic fibrosis (CF), a technique…
The Boomer Esiason Foundation (BEF) announced the Sacks for CF Scholarship for 2016-17, which are funding grants for…
The 30th Annual North American Cystic Fibrosis Conference (NACFC), a three-day collaborative forum to help advance cystic fibrosis (CF)…
A team of 12 research partners in seven European countries are engaged in a project to develop a mobile app designed to…
Vertex Pharmaceuticals reported that the U.S. Food and Drug Administration (FDA) has granted approval for its cystic fibrosis (CF)…
ProQR Therapeutics announced that it plans to announce proof-of-concept results from tests of its lead candidate to treat cystic fibrosis…
Irish CF Groups Disappointed in Government’s Funding Rejection of Orkambi as Not Cost Effective
Ireland’s National Centre for Pharmacoeconomics (NCPE) stirred the pot this week with its decision that the cost of the…
Researchers at Eindhoven University of Technology (Technische Universiteit Eindhoven-TU/e), in the Netherlands, have developed a device that…
A new technique using relatively inexpensive Microsoft Xbox Kinect gaming devices could soon be used to assess the respiratory health…